Algorithm Pipeline
Innovative diagnostic tools for detecting rare and hidden disease, based on the world’s largest labeled patient dataset, built to be integrated into existing physician workflows and currently pursuing FDA approval.
Program
Development
Pre-Submission
Validation
Submission
Approval
Low Ejection Fraction
Breakthrough designation*
Pulmonary Hypertension
Breakthrough designation*
Hypertrophic Cardiomyopathy
Amyloidosis
Atrial Fibrillation in Normal Sinus Rhythm
Aortic Stenosis
Myocarditis
Early Stage Development Programs
Low Ejection Fraction
Breakthrough designation*
Phase: Validation
Pulmonary Hypertension
Breakthrough designation*
Phase: Development
Hypertrophic Cardiomyopathy
Phase: Development
Amyloidosis
Phase: Development
Atrial Fibrillation in Normal Sinus Rhythm
Phase: Development
Aortic Stenosis
Phase: Development
Myocarditis
Phase: Development
Early Stage Development Programs
Phase: Development
*Granted FDA Breakthrough Designation
Partner with us!
We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to info@anumana.net
Let's Connect
